← Back to Clinical Trials
Recruiting NCT06018961

NCT06018961 Study of Postoperative Ileus in Digestive Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06018961
Status Recruiting
Phase
Sponsor University Hospital, Toulouse
Condition Colorectal Surgery
Study Type OBSERVATIONAL
Enrollment 161 participants
Start Date 2024-04-24
Primary Completion 2026-06-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Post-operative ileus surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 161 participants in total. It began in 2024-04-24 with a primary completion date of 2026-06-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Post-operative ileus is a temporary stoppage of bowel function following surgery. Indeed it can occur in 20% of cases during post-operative follow-up of bowel surgery. The absence of resumption of transit can lead to the implementation of specific treatments such as the placement of a nasogastric tube and drug treatments. To date, the definition of this event is not accepted by everyone and is not based on reproducible evaluation criteria. The main objective of this study is to evaluate a score used to date to define postoperative ileus, the IFEED score, and to compare it to the length of postoperative stay.

Eligibility Criteria

Inclusion Criteria: * Patient entering our care sector for surgical management of a pathology affecting the digestive tract: * Colorectal cancer * Chronic inflammatory bowel disease * Colonic diverticulosis. Exclusion Criteria: * Patient treated for digestive resection with associated resection procedure or to be treated with intraperitoneal chemotherapy. * Patient presenting during hospitalization with an ileus secondary to another intra-abdominal complication. * Patient cared for in an emergency * Hepatic resection or other associated metastatic site * Multiple digestive resection * Colorectal anastomosis less than 7 cm from the anal margin (below the Pouch of Douglas) * Patient with American Society of Anesthesiologists physical status (ASA) score \> 2 * Patient with an Eastern Cooperative Oncology Group (ECOG) Performance Status Scale \>2 * Pregnant or breastfeeding women * Patient under a protection regime for adults (guardianship, curators, safeguard of justice)

Contact & Investigator

Central Contact

Guillaume LE COSQUER, MD

✉ lecosquer.g@chu-toulouse.fr

📞 5 61 32 27 61

Principal Investigator

Guillaume LE COSQUER, MD

PRINCIPAL INVESTIGATOR

University Hospital, Toulouse

Frequently Asked Questions

Who can join the NCT06018961 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06018961 currently recruiting?

Yes, NCT06018961 is actively recruiting participants. Contact the research team at lecosquer.g@chu-toulouse.fr for enrollment information.

Where is the NCT06018961 trial being conducted?

This trial is being conducted at Toulouse, France, Toulouse, France.

Who is sponsoring the NCT06018961 clinical trial?

NCT06018961 is sponsored by University Hospital, Toulouse. The principal investigator is Guillaume LE COSQUER, MD at University Hospital, Toulouse. The trial plans to enroll 161 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology